Emin Aghayev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Emin Aghayev has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Haschtmann
Schulthess-Klinik, Zürich, Switzerland
2 shared publications - Andrew L. Avins
Kaiser Permanente Northern California
1 shared publication Anne F. Mannion
Spine Centre, Schulthess Clinic, Lengghalde, Zurich, Switzerland
1 shared publication- Anne Frances Mannion
Schulthess Klinik, Zürich, Switzerland
1 shared publication - Christian Herrmann
EUROSPINE, the Spine Society of Europe, Uster, Switzerland
1 shared publication - Christoph Röder
Krankenhaus Baden/Mödling
1 shared publication
Latest Publications
- Open Access
- 8 January 2026
- Published by Elsevier in Brain and Spine
- Vol. 6
Swiss national spinal implant registry SIRIS Spine: methods and first results
- 8 January 2026
- Published by Elsevier in Brain and Spine
- Vol. 6
Open AccessSwiss national spinal implant registry SIRIS Spine: methods and first results
- 20 November 2025
- Published by Springer Nature in European Spine Journal
- Vol. 35 (6) , 3267-3277
A crosswalk for the conversion of scores between the Neck Disability Index (NDI) and the neck version of the Core Outcome Measures Index (COMI-neck)
- 20 November 2025
- Published by Springer Nature in European Spine Journal
- Vol. 35 (6) , 3267-3277
A crosswalk for the conversion of scores between the Neck Disability Index (NDI) and the neck version of the Core Outcome Measures Index (COMI-neck)
- Open Access
- 7 November 2025
- Published by Zaporizhzhia State Medical and Pharmaceutical University in Zaporozhye Medical Journal
- Vol. 27 (5) , 382-390
Diagnostic and therapeutic tactics for patients with acute limb ischemia due to prolonged tourniquet application: a retrospective analysis and clinical outcomes
Patients with prolonged tourniquet application represent an understudied problem. The lack of clear national or international standards for care complicates the regulation of treatment tactics. The aim of this study was to develop and evaluate an algorithm for the care of patients with acute lower limb ischemia caused by prolonged (>2 hours) tourniquet application. Materials and methods. A retrospective analysis of 142 patients (mean age 36.71 ± 0.82 years) with isolated lower limb trauma and a tourniquet applied to the thigh for >2 hours was conducted at Communal Non-Profit Enterprise “Zaporizhzhia Regional Clinical Hospital” of Zaporizhzhia Regional Council from 2023 to July 2025. Patients were divided into two groups: a control group (2023, n = 64), who received unsystematic care, and a main group (from May 2024, n = 78), who were treated using the algorithm. These were further stratified into subgroups: A (2–4 hours), B (4–6 hours), and C (>6 hours). The algorithm was structured as follows: tourniquet removal at 4 hours without contractures; amputation in cases of contractures. The analysis included a comparison of laboratory parameters (potassium, pH, and lactate) upon admission and 24–48 hours later, as well as amputation rates. Results. Laboratory parameters upon admission did not correlate with ischemia time (p > 0.05). In subgroup B, the algorithm reduced the increase in potassium (0.20 mmol/L vs. 0.67 mmol/L, p = 0.02) and decreased the rate of delayed amputations (6.25 % vs. 44.4 %). The overall frequency of amputations was similar (50.00 % vs. 61.11 %), but the rate of primary amputations increased (43.8 % vs. 16.7 %), which led to a reduction in reperfusion complications. Conclusions. The algorithm is effective in protracted conflicts with evacuation delays, allowing for the intraoperative assessment of muscles and avoiding unjustified reperfusion. It reduces delayed amputations and complications without increasing the overall frequency of amputations, highlighting the limitations of laboratory markers. The algorithm could form the basis of national guidelines but requires multicenter prospective validation.
- 7 November 2025
- Published by Zaporizhzhia State Medical and Pharmaceutical University in Zaporozhye Medical Journal
- Vol. 27 (5) , 382-390
Open AccessDiagnostic and therapeutic tactics for patients with acute limb ischemia due to prolonged tourniquet application: a retrospective analysis and clinical outcomes
Patients with prolonged tourniquet application represent an understudied problem. The lack of clear national or international standards for care complicates the regulation of treatment tactics. The aim of this study was to develop and evaluate an algorithm for the care of patients with acute lower limb ischemia caused by prolonged (>2 hours) tourniquet application. Materials and methods. A retrospective analysis of 142 patients (mean age 36.71 ± 0.82 years) with isolated lower limb trauma and a tourniquet applied to the thigh for >2 hours was conducted at Communal Non-Profit Enterprise “Zaporizhzhia Regional Clinical Hospital” of Zaporizhzhia Regional Council from 2023 to July 2025. Patients were divided into two groups: a control group (2023, n = 64), who received unsystematic care, and a main group (from May 2024, n = 78), who were treated using the algorithm. These were further stratified into subgroups: A (2–4 hours), B (4–6 hours), and C (>6 hours). The algorithm was structured as follows: tourniquet removal at 4 hours without contractures; amputation in cases of contractures. The analysis included a comparison of laboratory parameters (potassium, pH, and lactate) upon admission and 24–48 hours later, as well as amputation rates. Results. Laboratory parameters upon admission did not correlate with ischemia time (p > 0.05). In subgroup B, the algorithm reduced the increase in potassium (0.20 mmol/L vs. 0.67 mmol/L, p = 0.02) and decreased the rate of delayed amputations (6.25 % vs. 44.4 %). The overall frequency of amputations was similar (50.00 % vs. 61.11 %), but the rate of primary amputations increased (43.8 % vs. 16.7 %), which led to a reduction in reperfusion complications. Conclusions. The algorithm is effective in protracted conflicts with evacuation delays, allowing for the intraoperative assessment of muscles and avoiding unjustified reperfusion. It reduces delayed amputations and complications without increasing the overall frequency of amputations, highlighting the limitations of laboratory markers. The algorithm could form the basis of national guidelines but requires multicenter prospective validation.
- Open Access
- 1 October 2025
- Published by Elsevier in Brain and Spine
- Vol. 5, 105622
Mapping healthcare services and practice variations in spinal care across countries: The Spine Atlas Initiative
- 1 October 2025
- Published by Elsevier in Brain and Spine
- Vol. 5, 105622
Open AccessMapping healthcare services and practice variations in spinal care across countries: The Spine Atlas Initiative
- 1 April 2020
- Published by Elsevier in World Neurosurgery
- Vol. 136, e270-e283
Risk Factors for Negative Global Treatment Outcomes in Lumbar Spinal Stenosis Surgery: A Mixed Effects Model Analysis of Data from an International Spine Registry
- 1 April 2020
- Published by Elsevier in World Neurosurgery
- Vol. 136, e270-e283
Risk Factors for Negative Global Treatment Outcomes in Lumbar Spinal Stenosis Surgery: A Mixed Effects Model Analysis of Data from an International Spine Registry
- Open Access
- 2 May 2019
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 40 (5) , 908-915
Lumbar Spinal Stenosis Severity by CT or MRI Does Not Predict Response to Epidural Corticosteroid versus Lidocaine Injections
BACKGROUND AND PURPOSE: Epidural steroid injections may offer little-to-no short-term benefit in the overall population of patients with symptomatic spinal stenosis compared with lidocaine alone. We investigated whether imaging could identify subgroups of patients who might benefit most. MATERIALS AND METHODS: A secondary analysis of the Lumbar Epidural Steroid Injections for Spinal Stenosis prospective, double-blind trial was performed, and patients were randomized to receive an epidural injection of lidocaine with or without corticosteroids. Patients (n = 350) were evaluated for qualitative and quantitative MR imaging or CT measures of lumbar spinal stenosis. The primary clinical end points were the Roland-Morris Disability Questionnaire and the leg pain numeric rating scale at 3 weeks following injection. ANCOVA was used to assess the significance of interaction terms between imaging measures of spinal stenosis and injectate type on clinical improvement. RESULTS: There was no difference in the improvement of disability or leg pain scores at 3 weeks between patients injected with epidural lidocaine alone compared with corticosteroid and lidocaine when accounting for the primary imaging measures of qualitative spinal stenosis assessment (interaction coefficients for disability score, −0.1; 95% CI, −1.3 to 1.2; P = .90; and for the leg pain score, 0.1; 95% CI, −0.6 to 0.8; P = .81) or the quantitative minimum thecal sac cross-sectional area (interaction coefficients for disability score, 0.01; 95% CI, −0.01 to 0.03; P = .40; and for the leg pain score, 0.01; 95% CI, −0.01 to 0.03; P = .33). CONCLUSIONS: Imaging measures of spinal stenosis are not associated with differential clinical responses following epidural corticosteroid injection.
- 2 May 2019
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 40 (5) , 908-915
Open AccessLumbar Spinal Stenosis Severity by CT or MRI Does Not Predict Response to Epidural Corticosteroid versus Lidocaine Injections
BACKGROUND AND PURPOSE: Epidural steroid injections may offer little-to-no short-term benefit in the overall population of patients with symptomatic spinal stenosis compared with lidocaine alone. We investigated whether imaging could identify subgroups of patients who might benefit most. MATERIALS AND METHODS: A secondary analysis of the Lumbar Epidural Steroid Injections for Spinal Stenosis prospective, double-blind trial was performed, and patients were randomized to receive an epidural injection of lidocaine with or without corticosteroids. Patients (n = 350) were evaluated for qualitative and quantitative MR imaging or CT measures of lumbar spinal stenosis. The primary clinical end points were the Roland-Morris Disability Questionnaire and the leg pain numeric rating scale at 3 weeks following injection. ANCOVA was used to assess the significance of interaction terms between imaging measures of spinal stenosis and injectate type on clinical improvement. RESULTS: There was no difference in the improvement of disability or leg pain scores at 3 weeks between patients injected with epidural lidocaine alone compared with corticosteroid and lidocaine when accounting for the primary imaging measures of qualitative spinal stenosis assessment (interaction coefficients for disability score, −0.1; 95% CI, −1.3 to 1.2; P = .90; and for the leg pain score, 0.1; 95% CI, −0.6 to 0.8; P = .81) or the quantitative minimum thecal sac cross-sectional area (interaction coefficients for disability score, 0.01; 95% CI, −0.01 to 0.03; P = .40; and for the leg pain score, 0.01; 95% CI, −0.01 to 0.03; P = .33). CONCLUSIONS: Imaging measures of spinal stenosis are not associated with differential clinical responses following epidural corticosteroid injection.
- Open Access
- 8 April 2009
- Published by Springer Nature in European Spine Journal
- Vol. 18 (6) , 862
SWISSspine: a nationwide registry for health technology assessment of lumbar disc prostheses
- 8 April 2009
- Published by Springer Nature in European Spine Journal
- Vol. 18 (6) , 862
Open AccessSWISSspine: a nationwide registry for health technology assessment of lumbar disc prostheses